The serodiagnosis of human psittacosis was considerably improved by a microimmunofluorescence (MIF) assay that uses selected strains of Chiamydia psittaci, C. pneumoniae, and C. trachomatis as antigens. Infections with Chlamydia psittaci in humans may range from clinically inapparent to severe systemic infections involving multiple organs and pneumonia. Accurate and timely diagnosis of human psittacosis is difficult because of the lack of distinctive clinical symptoms and sufficiently sensitive and specific laboratory tests (4). Complement fixation (CF) with antigen extracts from C. psittaci has been used most commonly for the laboratory diagnosis of psittacosis. It is a genus-specific test that detects antibodies common to all chlamydial species but is relatively insensitive for the detection of a current infection. With the recent recognition that C. pneumoniae is an important etiologic agent that causes respiratory syndromes similar to those caused by C. psittaci but with marked epidemiologic and microbiologic differences, it has become apparent that more specific and sensitive diagnostic methods are needed for the epidemiologic investigation and control of these diseases.
Infections with Chlamydia psittaci in humans may range from clinically inapparent to severe systemic infections involving multiple organs and pneumonia. Accurate and timely diagnosis of human psittacosis is difficult because of the lack of distinctive clinical symptoms and sufficiently sensitive and specific laboratory tests (4) . Complement fixation (CF) with antigen extracts from C. psittaci has been used most commonly for the laboratory diagnosis of psittacosis. It is a genus-specific test that detects antibodies common to all chlamydial species but is relatively insensitive for the detection of a current infection. With the recent recognition that C. pneumoniae is an important etiologic agent that causes respiratory syndromes similar to those caused by C. psittaci but with marked epidemiologic and microbiologic differences, it has become apparent that more specific and sensitive diagnostic methods are needed for the epidemiologic investigation and control of these diseases.
Recently, investigators used the microimmunofluorescence (MIF) assay (12, 13) to reexamine cases previously indicated by the CF test to be psittacosis. Their studies (2, 7, 8, 15) retrospectively identified several outbreaks of C. pneumoniae in different countries. The MIF test has been extensively applied to the study of diseases caused by C. trachomatis and C. pneumoniae, but its potential usefulness for the serodiagnosis of human psittacosis has scarcely been explored. In the present study, we investigated the use of the MIF assay with selected strains of C. psittaci, C. pneumoniae, and C. trachomatis as antigens to enhance the efficiency and accuracy for the diagnosis of human psittacosis. The results were compared with those of the standard CF test. Four distinctive serologic reaction patterns were observed with the study sera, and their relevance to the serodiagnosis of psittacosis is discussed.
MATERIALS AND METHODS
Bacteria and antigens. Eight strains of C. psittaci isolated from different host species were used: 6BC (parakeet), TT' (turkey), DD34 (parrot), CP3 (pigeon), WS (calf), B577 (aborted ovine fetus), FP1 (cat), and GPIC1 (guinea pig conjunctiva). The seed cultures were purchased from the American Type Culture Collection, Rockville, Md. C. pneumoniae TW183 was obtained from the Washington Research Foundation, Seattle.
The seed cultures of C. psittaci and C. pneumoniae were grown in H-292 or HEp-2 cells in tissue culture plates as described previously (14) . Chlamydiae were harvested from infected tissue cells by sonication for 20 s, and the cellular debris was removed by centrifugation (500 x g, 20 min, 4°C).
Elementary bodies were pelleted at 30,000 x g for 30 min, resuspended, and homogenized in phosphate-buffered saline (PBS; pH 7.3) containing 0.02% formalin.
The chlamydial antigen suspensions were examined by the MIF assay (12, 13) psittaci-specific IgM-positive, high IgG titers to C. psittaci, with lower titers to C. pneumoniae and C. trachomatis (patient 1), IgM-negative, fourfold rise in IgG titers to all three species (patient 2), C. psittaci-specific IgM-positive, high IgG titer to C. psittaci, with modest activities to C. pneumoniae and C. trachomatis (patient 3), and IgM-negative, high IgG activities to all three species (patient 4). Si and S2, first and second serum specimens from patients, respectively; NT, not tested. b Sera were tested by the MIF assay with eight strains of C. psittaci, C. pneumoniae TW183, and three pools of C. trachomatis serovars. Representative results for C. psittaci (from strain DD34) and C. trachomatis (from pool 1 serovars B, E, and D) are presented. Titers to the other C. psittaci strains and C. trachomatis pools were identical or similar, as discussed in the text. pneumoniae as the infecting agent. The CF test titers of these sera, if any, were low and seldom exceeded 1 
DISCUSSION
The results of the present study demonstrate several points of significance concerning the serodiagnosis of human psittacosis. First, the MIF test with appropriate strains of C. psittaci, C. pneumoniae, and C. trachomatis used as antigens enhanced the efficiency and accuracy of the serodiagnosis of human psittacosis in comparison with the results obtained by the conventional CF test. Of the 78 study patients who were clinically diagnosed as having psittacosis on the basis of symptoms and exposure to sick birds prior to the onset of illness, the sera of 36 patients (46%) were CF test positive, with antibody activities to C. psittaci detected by the MIF assay. In In some sera that were drawn periodically from patients with psittacosis during a period of 3 to 4 months after the onset of clinical symptoms, the modest IgG titers (16 to 64) to C. pneumoniae and C. trachomatis remained unchanged from those of the patients' first serum specimens, while the IgG activities to C. psittaci rose, fell, or were unchanged at relatively high titers (256 to .512). The most likely source of the IgG titers to C. pneumoniae and C. trachomatis in these patients was from a previous exposure not related to the current infection with C. psittaci, because infections with C. pneumoniae and C. trachomatis are known to be widespread.
(ii) In another group of patients, high IgG titers (256 to -512) to all three chlamydial species were detected by the MIF test. These patients were identified as having psittacosis because of exposure to sick birds implicated in psittacosis outbreaks, compatible clinical symptoms, and relatively high CF antibody titers in clinical sera ranging from 128 to .512. The IgG titers to C. pneumoniae and C. trachomatis in the majority of these patients remained as high as the IgG titers to C. psittaci in follow-up specimens. Frequently, the titers to C. pneumoniae and C. trachomatis also rose or fell proportionally with the titers to C. psittaci. Since the MIF test primarily detects surface antigens and the genus-specific lipopolysaccharide antigen is not a major surface antigen, these results suggest the presence in the infecting strains of a C. psittaci surface antigen(s) that cross-reacted with C. pneumoniae and C. trachomatis. Theoretically, these cross-reacting antigens may also induce secondary antibody responses as a result of previous exposure to C. pneumoniae and C. trachomatis. The antigenic diversity of C. psittaci strains has been well documented (1, 3, 6, (9) (10) (11) .
Recognition of the different reaction patterns of sera from patients with psittacosis would be very useful in the application of the MIF test to improving the serodiagnosis of the disease.
Fourth, in the majority of patients the antibody titers to the eight strains of C. psittaci used as antigens in the MIF test were similar. However, in the patients in whose sera differences in titers to these antigens were observed, the titers to the mammalian strains were invariably lower, and when different titers were detected among the avian strains, strain DD34 (parrot) most often yielded titers 1 to 2 dilutions greater than those yielded by strains 6BC (parakeet), TT (turkey), and CP3 (pigeon). These results indicate that the infecting strains of these patients were antigenically more closely related to strain DD34. However, the differences were not great enough to change the diagnosis for these patients, and strain DD34 with either strain 6BC or strain TT appeared to provide adequate antigenic coverage for diagnosis by the MIF test because almost all human cases of infection in the United States are associated with infected birds or poultry.
In conclusion, with the recognition of the serologic reaction patterns of patients with psittacosis, the use of the MIF test with the selected strains of C. psittaci, C. pneumoniae, and C. trachomatis as antigens should enhance the efficiency and accuracy of serodiagnosis of human psittacosis. Because of similarities in clinical symptoms, the close antigenic relationship among the chlamydial species, and the prevalence of IgG antibodies to C. pneumoniae and C. trachomatis in the population, judicious corroboration of serologic results obtained by the MIF test with epidemiologic and clinical information is essential for an accurate diagnosis. The MIF test appears to be more advantageous than the conventional CF test, and those laboratories with proficiency in the serodiagnosis of C. pneumoniae and C. trachomatis infections may readily expand the MIF procedure to include C. psittaci serology. However, both the MIF and CF procedures are technically demanding, timeconsuming, and costly; quality reagents are not readily available. Tests that are more practical for routine use are needed for the laboratory diagnosis of human psittacosis.
